Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tracy Marshbanks Insider Profile
4 Followers
Tracy Marshbanks, Director at ANI Pharmaceuticals, holds 349.93K shares in ANI Pharmaceuticals (Ticker: ANIP). Most recently, Tracy Marshbanks Sold $38,236 shares of ANI Pharmaceuticals on May 16, 2018 for an estimated value of 2.38M.
Profitable Transactions
1 out of 8 Profitable Transactions
Average Return
-34.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tracy Marshbanks's holdings
Insider Roles
Director
Roles that Tracy Marshbanks holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 16, 2015 - Mar 16, 2016
Return:+50.00%
The most profitable trade made by Tracy Marshbanks
Tracy Marshbanks's Trading History
List of latest transactions for each holding click on a transaction to see Tracy Marshbanks's performance on stock
You May Also Like
Tracy Marshbanks insider profile FAQ
What is the percentage of profitable transactions made by Tracy Marshbanks?
The percentage of profitable transactions made by Tracy Marshbanks is 13%.
What is the average return per transaction made by Tracy Marshbanks?
The average return per transaction made by Tracy Marshbanks is -34.50%.
What stocks does Tracy Marshbanks hold?
Tracy Marshbanks holds: ANIP stocks.
What was Tracy Marshbanks’s latest transaction?
Tracy Marshbanks latest transaction was an Informative Sell of $2.38M.
What was Tracy Marshbanks's most profitable transaction?
Tracy Marshbanks’s most profitable transaction was an Informative Sell of ANIP stock on March 16, 2015. The return on the trade was 50.00%.
What is Tracy Marshbanks's role in ANI Pharmaceuticals?
Tracy Marshbanks's role in ANI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.